Literature DB >> 3034767

Catabolism of homologous murine monoclonal hybridoma IgG antibodies in mice.

P J Talbot, M J Buchmeier.   

Abstract

Two neutralizing monoclonal hybridoma antibodies to the surface spike glycoprotein E2 of the JHM strain of murine hepatitis virus were injected into homologous BALB/c mice, and their biological half-lives were determined by sequential titration of plasma samples in a virus-specific enzyme immunoassay. Intravascular half-lives of monomeric immunoglobulins were estimated at 8.0 +/- 1.5 days for antibody 5B19.3, an IgG1, and 12.7 +/- 2.4 days for antibody 4B11.6, an IgG2a. These catabolic rates are statistically different from each other (P less than 0.001) and significantly higher than previously reported values, which were all obtained with radiolabelled polyclonal or myeloma immunoglobulins of unknown specificities. Failure to remove aggregated 4B11.6 antibodies by high-speed centrifugation yielded a statistically significant acceleration of biological turnover (half-life 9.9 +/- 1.6 days; P less than 0.01).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3034767      PMCID: PMC1453269     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  33 in total

1.  Catabolism of gamma-globulin by the isolated perfused rat liver.

Authors:  S COHEN; A H GORDON; C MATTHEWS
Journal:  Biochem J       Date:  1962-01       Impact factor: 3.857

2.  THE METABOLISM OF NORMAL PLASMA PROTEINS AND GAMMA-MYELOMA PROTEIN IN MICE BEARING PLASMA-CELL TUMORS.

Authors:  J H Humphrey; J L Fahey
Journal:  J Clin Invest       Date:  1961-09       Impact factor: 14.808

3.  Effect of cold exposure on the metabolism of immunoglobulins in rabbits.

Authors:  B H Sabiston; J E Rose
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

4.  Metabolism and passive transfer of immunoglobulins in the turkey hen.

Authors:  J E Dohms; Y M Saif; W L Bacon
Journal:  Am J Vet Res       Date:  1978-09       Impact factor: 1.156

5.  MRL mice show an age-related impairment of IgG aggregate removal from the circulation.

Authors:  M Field; F M Brennan; R D Melsom; D McCarthy; P Mumford; R N Maini
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

6.  Identification of the sites of IgG catabolism in the rat.

Authors:  L A Henderson; J W Baynes; S R Thorpe
Journal:  Arch Biochem Biophys       Date:  1982-04-15       Impact factor: 4.013

7.  Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence.

Authors:  R G Dalziel; P W Lampert; P J Talbot; M J Buchmeier
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

8.  Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody.

Authors:  M J Buchmeier; H A Lewicki; P J Talbot; R L Knobler
Journal:  Virology       Date:  1984-01-30       Impact factor: 3.616

9.  POTENTIATION OF THE LETHAL EFFECT OF ENDOTOXIN BY HETEROLOGOUS PLASMA.

Authors:  F K BELLER; C H DEBROVNER; G W DOUGLAS
Journal:  J Exp Med       Date:  1963-08-01       Impact factor: 14.307

10.  EVIDENCE FOR SPECIES' DIFFERENCES IN THE EFFECT OF SERUM GAMMA-GLOBULIN CONCENTRATION ON GAMMA-GLOBULIN CATABOLISM.

Authors:  S SELL
Journal:  J Exp Med       Date:  1964-11-01       Impact factor: 14.307

View more
  14 in total

1.  Induction of antiviral antibodies by DNA immunization requires neither perforin-mediated nor CD8(+)-T-cell-mediated lysis of antigen-expressing cells.

Authors:  D E Hassett; J Zhang; J L Whitton
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Protective long-term antibody memory by antigen-driven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs.

Authors:  A F Ochsenbein; D D Pinschewer; S Sierro; E Horvath; H Hengartner; R M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

3.  Multivalent recombinant proteins for probing functions of leucocyte surface proteins such as the CD200 receptor.

Authors:  Despina Voulgaraki; Rita Mitnacht-Kraus; Michelle Letarte; Mildred Foster-Cuevas; Marion H Brown; A Neil Barclay
Journal:  Immunology       Date:  2005-07       Impact factor: 7.397

4.  Antiviral antibodies attenuate T-cell-mediated immunopathology following acute lymphocytic choriomeningitis virus infection.

Authors:  K E Wright; M J Buchmeier
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

Review 5.  Long-term humoral immunity against viruses: revisiting the issue of plasma cell longevity.

Authors:  M K Slifka; R Ahmed
Journal:  Trends Microbiol       Date:  1996-10       Impact factor: 17.079

6.  Differential impact of ageing on cellular and humoral immunity to a persistent murine gamma-herpesvirus.

Authors:  Eric J Yager; In-Jeong Kim; Michael L Freeman; Kathleen G Lanzer; Claire E Burkum; Tres Cookenham; David L Woodland; Marcia A Blackman
Journal:  Immun Ageing       Date:  2010-02-02       Impact factor: 6.400

7.  Half-life of polyreactive antibodies.

Authors:  G Sigounas; N Harindranath; G Donadel; A L Notkins
Journal:  J Clin Immunol       Date:  1994-03       Impact factor: 8.317

8.  Human immune memory to yellow fever and smallpox vaccination.

Authors:  Jens Wrammert; Joe Miller; Rama Akondy; Rafi Ahmed
Journal:  J Clin Immunol       Date:  2008-12-04       Impact factor: 8.317

9.  Attenuation of induced hyperthyroidism in mice by pretreatment with thyrotropin receptor protein: deviation of thyroid-stimulating to nonfunctional antibodies.

Authors:  Alexander V Misharin; Yuji Nagayama; Holly A Aliesky; Yumiko Mizutori; Basil Rapoport; Sandra M McLachlan
Journal:  Endocrinology       Date:  2009-04-23       Impact factor: 4.736

10.  Distinct B-cell populations contribute to vaccine antigen-specific antibody production in a transgenic mouse model.

Authors:  Eunju O; Eun-Ju Ko; Min-Chul Kim; Young-Tae Lee; Jae-Min Song; Young-Man Kwon; Richard W Compans; Sang-Moo Kang
Journal:  Immunology       Date:  2014-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.